Book contents
- International Compendium of Movement Disorders
- International Compendium of Movement Disorders
- Copyright page
- Contents
- Contributors
- International Compendium of Movement Disorders
- Hypo- and Hyperkinetic, Dyscoordinative and Otherwise Inappropriate Motor and Behavioral Movement Disorders
- Section 1: Basic Introduction
- Section 2: Hypokinetic Movement Disorders
- Chapter 12 Autonomic Dysfunction in Parkinson’s Disease
- Chapter 13 Neuropsychiatric Manifestations in Parkinson Disease
- Chapter 14 Sleep–Wake Disorders in Parkinson’s Disease
- Chapter 15 Neuronal Activity in the Basal Ganglia and Thalamus in Patients with Parkinson’s Disease
- Chapter 16 Pathology in Parkinson’s Disease
- Chapter 17 Diagnosis of Parkinson’s Disease
- Chapter 18 Prodromal Manifestations of Parkinson’s Disease
- Chapter 19 Biomarkers in Parkinson’s Disease
- Chapter 20 Physical Rehabilitation of Patients with Parkinson’s Disease
- Chapter 21 Regenerative Strategies for Parkinson’s Disease
- Chapter 22 Conventional Pharmacotherapy in Parkinson’s Disease
- Chapter 23 Continuous Dopaminergic Stimulation in Parkinson’s Disease
- Chapter 24 Pipeline of Pharmacotherapy in Parkinson’s Disease
- Chapter 25 Non-Invasive Brain Stimulation for the Treatment of Parkinson’s Disease
- Chapter 26 Deep Brain Stimulation in Parkinson’s Disease
- Chapter 27 Focused Ultrasound in Parkinson’s Disease
- Chapter 28 Dementia with Lewy Bodies
- Chapter 29 Genetic Parkinsonisms
- Chapter 30 Multiple System Atrophy
- Chapter 31 Progressive Supranuclear Palsy
- Chapter 32 Corticobasal Degeneration and Corticobasal Syndrome
- Chapter 33 Other Tau-Related Parkinsonisms
- Chapter 34 Vascular Parkinsonism
- Chapter 35 Illicit Drug–Induced Parkinsonism
- Section 3: Hyperkinetic Movement Disorders
- Section 4: Dyscoordinative and Otherwise Inappropriate Motor Behaviors
- Section 5: Objectifying Movement Disorders
- Movement Disorders in Vivo: Video Fragments
- Acronyms and Abbreviations
- Index
- References
Chapter 22 - Conventional Pharmacotherapy in Parkinson’s Disease
from Section 2: - Hypokinetic Movement Disorders
Published online by Cambridge University Press: 07 January 2025
- International Compendium of Movement Disorders
- International Compendium of Movement Disorders
- Copyright page
- Contents
- Contributors
- International Compendium of Movement Disorders
- Hypo- and Hyperkinetic, Dyscoordinative and Otherwise Inappropriate Motor and Behavioral Movement Disorders
- Section 1: Basic Introduction
- Section 2: Hypokinetic Movement Disorders
- Chapter 12 Autonomic Dysfunction in Parkinson’s Disease
- Chapter 13 Neuropsychiatric Manifestations in Parkinson Disease
- Chapter 14 Sleep–Wake Disorders in Parkinson’s Disease
- Chapter 15 Neuronal Activity in the Basal Ganglia and Thalamus in Patients with Parkinson’s Disease
- Chapter 16 Pathology in Parkinson’s Disease
- Chapter 17 Diagnosis of Parkinson’s Disease
- Chapter 18 Prodromal Manifestations of Parkinson’s Disease
- Chapter 19 Biomarkers in Parkinson’s Disease
- Chapter 20 Physical Rehabilitation of Patients with Parkinson’s Disease
- Chapter 21 Regenerative Strategies for Parkinson’s Disease
- Chapter 22 Conventional Pharmacotherapy in Parkinson’s Disease
- Chapter 23 Continuous Dopaminergic Stimulation in Parkinson’s Disease
- Chapter 24 Pipeline of Pharmacotherapy in Parkinson’s Disease
- Chapter 25 Non-Invasive Brain Stimulation for the Treatment of Parkinson’s Disease
- Chapter 26 Deep Brain Stimulation in Parkinson’s Disease
- Chapter 27 Focused Ultrasound in Parkinson’s Disease
- Chapter 28 Dementia with Lewy Bodies
- Chapter 29 Genetic Parkinsonisms
- Chapter 30 Multiple System Atrophy
- Chapter 31 Progressive Supranuclear Palsy
- Chapter 32 Corticobasal Degeneration and Corticobasal Syndrome
- Chapter 33 Other Tau-Related Parkinsonisms
- Chapter 34 Vascular Parkinsonism
- Chapter 35 Illicit Drug–Induced Parkinsonism
- Section 3: Hyperkinetic Movement Disorders
- Section 4: Dyscoordinative and Otherwise Inappropriate Motor Behaviors
- Section 5: Objectifying Movement Disorders
- Movement Disorders in Vivo: Video Fragments
- Acronyms and Abbreviations
- Index
- References
Summary
This chapter deals with the pharmacotherapy of motor clinical hallmarks in Parkinson’s disease (PD), plus other PD and/or its intervention-related signs and symptoms. The treatment of PD-related non-dopaminergic symptoms such as mainly autonomic, neuropsychiatric and sleep–wake disorders are extensively dealt with in other chapters, so the pharmacotherapy of these disorders are only be discussed briefly. Autonomic non-motor fluctuations comprise cardiovascular (orthostatic hypotension), urogenital (detrusor over- and underactivity-related problems, e.g., urgency, frequency, nocturia, hesitation and straining), and gastrointestinal manifestations (sialorrhea, dysphagia, delayed gastric emptying, constipation). Depression and (mild) cognitive impairment are the most important mainly direct PD-related neuropsychiatric disorders, whereas impulse control disorders, as well as dementia and psychosis, are frequently seen as dopaminomimetic adverse events. Sleep–wake disorders with parasomnias are also characteristic non-motor symptoms in PD. The tailored pharmacologic strategies in these non-dopaminergic symptoms are discussed in detail.
Keywords
- Type
- Chapter
- Information
- International Compendium of Movement Disorders , pp. 264 - 279Publisher: Cambridge University PressPrint publication year: 2025